CYTK

59.62

0.68% -0.41

시간 외 거래: 58.70 -0.92 -1.54%

Cytokinetics Inc (CYTK)

개요 뉴스 가격 이력 옵션 체인 Financials CYTK 왜 하락? 토론 예측 주식 분할

전일 마감가:

$60.03

열려 있는:

$59.55

하루 거래량:

978.98K

Relative Volume:

0.43

시가총액:

$7.13B

수익:

$18.47M

순이익/손실:

$-589.53M

주가수익비율:

-11.33

EPS:

-5.26

순현금흐름:

$-399.80M

1주 성능:

-3.79%

1개월 성능:

+4.65%

6개월 성능:

+59.63%

1년 성능:

+15.81%

1일 변동 폭

$58.95

$60.77

1주일 범위

$58.95

$64.13

52주 변동 폭

$29.31

$64.13

Cytokinetics Inc Stock (CYTK) Company Profile

명칭

Cytokinetics Inc

부문

Healthcare (1135)

산업

Biotechnology (635)

전화

(650) 624-3000

주소

350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA

직원

498

트위터

@Cytokinetics

다음 수익 날짜

2024-11-06

최신 SEC 제출 서류

CYTK's Discussions on Twitter

CYTK을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
CYTK Cytokinetics Inc	59.62	7.18B	18.47M	-589.53M	-399.80M	-5.26
VRTX Vertex Pharmaceuticals Inc	421.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	628.00	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	423.47	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	831.48	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	182.77	39.72B	447.02M	-1.18B	-906.14M	-6.1812

Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-07-30	재개	Raymond James	Mkt Perform
2025-04-24	개시	Barclays	Overweight
2025-02-07	개시	Citigroup	Buy
2025-01-22	개시	Stifel	Buy
2024-11-08	개시	RBC Capital Mkts	Outperform
2024-08-13	다운그레이드	Goldman	Buy → Neutral
2024-01-24	다운그레이드	UBS	Buy → Neutral
2024-01-05	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2023-11-09	개시	Goldman	Buy
2023-11-07	개시	B. Riley Securities	Buy
2023-08-15	개시	SVB Securities	Outperform
2023-02-17	개시	BofA Securities	Neutral
2022-12-23	재확인	Needham	Buy
2022-12-20	개시	Truist	Buy
2022-10-11	개시	UBS	Buy
2022-01-28	개시	Goldman	Buy
2021-12-22	개시	Oppenheimer	Outperform
2021-12-10	개시	JP Morgan	Overweight
2021-10-07	개시	Jefferies	Buy
2021-03-12	개시	Wolfe Research	Outperform
2021-02-18	개시	Barclays	Overweight
2021-01-20	재확인	H.C. Wainwright	Buy
2020-10-29	개시	Goldman	Neutral
2020-07-10	개시	Raymond James	Strong Buy
2020-05-05	개시	Mizuho	Buy
2020-04-09	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2018-09-21	개시	Cantor Fitzgerald	Overweight
2018-09-10	재개	Morgan Stanley	Equal-Weight
2017-11-22	재확인	Morgan Stanley	Overweight
2017-11-22	다운그레이드	Needham	Strong Buy → Buy
2017-11-21	재확인	H.C. Wainwright	Buy
2017-07-31	개시	Morgan Stanley	Overweight
2017-03-08	개시	Rodman & Renshaw	Buy
2017-02-06	업그레이드	Needham	Buy → Strong Buy
2016-12-16	개시	Cantor Fitzgerald	Overweight
2016-07-28	재확인	Needham	Buy
2015-11-10	재확인	FBR Capital	Outperform
2015-11-09	재확인	ROTH Capital	Buy
2015-07-24	재확인	MLV & Co	Buy
2014-12-31	재확인	ROTH Capital	Buy
2014-11-04	업그레이드	MLV & Co	Hold → Buy
2014-04-28	재확인	Needham	Buy

모두보기

Cytokinetics Inc 주식(CYTK)의 최신 뉴스

Nov 04, 2025

Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - GlobeNewswire Inc.

Nov 04, 2025

Insider Sell Alert: Fady Malik Sells Shares of Cytokinetics Inc (CYTK) - GuruFocus

Nov 04, 2025

Cytokinetics to Participate in November Investor Conferences - The Manila Times

Nov 04, 2025

Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Nov 04, 2025

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FinancialContent

Nov 04, 2025

Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors - GlobeNewswire

Nov 04, 2025